openPR Logo
Press release

Head of the US FDA Division of Pharmacometrics to Kick-off Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”

04-07-2011 03:14 PM CET | Science & Education

Press release from: Rosa and Co

Rosa Logo

Rosa Logo

Rosa & Co. LLC today announced that Dr. Jogarao V. Gobburu, Head of the US FDA Division of Pharmacometrics, will present the inaugural webinar in Rosa’s monthly public webinar series “Impact of Modeling & Simulation in Drug Development” ” on April 18, 2011 at 1:00 pm EDT (GMT -5:00). The purpose of the “Impact” series is to foster the use of Modeling and Simulation (M&S) activities in biotechnology, pharmaceutics, and other life science industries. This series will illustrate the advantages and enhancing the applicability of M&S in product discovery, development, and marketing programs. Dr. Gobburu’s talk, The “Learn & Apply” Paradigm in Drug Development, will summarize the state of the art in applying drug-disease-trial models to decision-making processes in drug development.
“PK/PD and physiologic M&S techniques have been established commercial disciplines for more than a decade,” said Dr. Ron Beaver, Rosa’s Founder and CEO. “However, the ultimate potential for these techniques to speed development, improve efficacy, and reduce costs is far from being realized. Our webinar series is designed to extend the ability of both providers and consumers of drug-disease M&S to recognize when and how these techniques can be harnessed in real-world applications throughout a product’s lifecycle.”
This webinar series will primarily focus on M&S of drug action, disease progression, and trial populations and outcomes. From time to time, special webinars will focus on related M&S topics of interest in product development; for example, scientifically-rigorous market modeling. The series is intended for project team members and executives from research through Phase IV clinical trials. This includes ADME scientists, PK/PD modelers, clinical pharmacologists, clinical development team members, regulatory affairs specialists, Chief Medical Officers or Scientists, and other interested professionals.
“Dr. Gobburu’s talk will provide valuable insights into the latest achievements of M&S in bringing much needed medicines to patients faster. As the head of the Division of Pharmacometrics at FDA, he is well placed to have a broad view of M&S activities in pharmaceutical companies and regulatory decision-making processes.” said Dr. Toufigh Gordi, the Coordinator of the “Impact” series and President of Rosa’s PK/PD and Clinical Pharmacology Services.
Register for this free webinar at www.rosaandco.com/webinar. After registering you will receive a confirmation email containing information about joining the webinar. More information about the webinar series, an archive of past webinars, and a list of future webinar speakers may be found at www.rosaandco.com/webinar.

Rosa informs our customer’s most critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of related issues, Rosa offers two customized approaches: classic pharmacokinetic/pharmacodynamic (PK/PD) models and Rosa’s innovative PhysioPD™ models. With these approaches, Rosa’s clients collaborate in model creation and testing, retain the final model, and acquire the ability to use it and understand its implications for their drug development programs. Rosa’s staff have close to two decades of unparalleled professional experience in using drug-disease modeling and simulation (M&S) to accelerate drug development; they have covered hundreds of applications with dozens of clients. The Rosa team is unique in their breadth and depth of disease area experience, which includes metabolic and cardiovascular diseases, oncology, gastro-intestinal disease, inflammatory diseases, immune dysfunction (including rheumatoid arthritis), pain, skin conditions, respiratory disorders, and antibacterials/antivirals. For more information, visit www.rosaandco.com.

751 Laurel St., Ste. 127,
San Carlos, CA 94070

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Head of the US FDA Division of Pharmacometrics to Kick-off Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development” here

News-ID: 170021 • Views:

More Releases for M&S

Burn Care Market ||Derma SciencesInc., Coloplast A/S, Mlnlycke Health Care
Zion Market Research published a new 110+ pages industry research "Burn Care Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016-2024" is exhaustively researched and analyzed in the report to help market players to improve their business tactics and ensure long-term success. The authors of the report have used easy-to-understand language and uncomplicated statistical images but provided thorough information and detailed data on the Global Burn Care Market.
M & S Security Services Offers Security Services in Bakersfield, CA
M&S Security Services is a rapidly growing security company with offices in Bakersfield and Taft. M & S Security Services has been offering security services to a wide range of customers for over forty years. The company deals with major corporations, small businesses, homes, churches, agri-business and government entities. M & S Security Services has been serving clients since 1972. M&S Security Servicesis a local family owned and operated
Laundry Baskets and Laundry Bins 2018 Market By Major Players: Argos, IKEA, KIS, …
The global Laundry Baskets & Laundry Bins market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/2367838?utm_source=Mohit Key manufacturers are included based on manufacturing
ALCOR M&A"S Private Equity Funds Well Positioned to Exploit Fundraising Boom
ALCOR M&A is a firm advising on a range of venture capital, private equity and corporate venturing transactions. We advise on all aspects throughout the funding lifecycle of a company, from early-stage investments, subsequent funding rounds, bridge financing, venture debt and equity reorganization, as well as exits via trade sales, management buyouts. Our venture capital and private equity group also advises numerous international and domestic corporate on strategic investments. We are
SUNRISE Select M/S Terramar among the TOP Nile Cruisers in Egypt
The extraordinary performance of SUNRISE Select MS Terramar resulted in a 100 % recommendation rate at "HolidayCheck" website. SUNRISE Select M/S Terramar exceeded its guest’s expectations regarding high-quality products and perfect service – an effort reflected by the reviews of users on HolidayCheck – the largest German language travel and holiday portal on the web today. The recommendation rate bases on the critical points like the cruiser in general, cabins, restaurants and
euNetworks deploys host|nex for S+M Schaltgeräte
INTEGRATED COMMUNICATIONS SOLUTION TO SUPPORT YOUTH PROTECTION IN SALES OF TOBACCO PRODUCTS Frankfurt/Germany, 08 April 2008 – euNetworks, (SGX: H23.SI), Europe’s foremost provider of mission-critical, extreme performance and capacity data services to large corporates, carriers and services providers, today announced it concluded an agreement with S+M Schaltgeräte Service und Vertriebs GmbH (S+M Schaltgeräte), one of the leading providers of Hard- and Software Solutions in Germany. Under the terms of the agreement,